tiprankstipranks
Trending News
More News >
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market
Advertisement

Puma Biotechnology (PBYI) Ratios

Compare
646 Followers

Puma Biotechnology Ratios

PBYI's free cash flow for Q2 2025 was $0.77. For the 2025 fiscal year, PBYI's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.73 1.57 1.73 1.28 1.28
Quick Ratio
1.62 1.50 1.67 1.21 1.25
Cash Ratio
0.69 0.85 0.98 0.58 0.75
Solvency Ratio
0.66 0.19 0.05 -0.08 -0.21
Operating Cash Flow Ratio
0.56 0.27 -0.20 0.19 <0.01
Short-Term Operating Cash Flow Coverage
1.16 0.79 0.00 5.79 0.05
Net Current Asset Value
$ 46.38M$ -20.90M$ -66.17M$ -89.01M$ -104.03M
Leverage Ratios
Debt-to-Assets Ratio
0.20 0.48 0.51 0.51 0.50
Debt-to-Equity Ratio
0.37 2.09 5.29 -48.60 -20.16
Debt-to-Capital Ratio
0.27 0.68 0.84 1.02 1.05
Long-Term Debt-to-Capital Ratio
0.09 0.55 0.82 1.03 1.08
Financial Leverage Ratio
1.86 4.31 10.28 -94.41 -40.70
Debt Service Coverage Ratio
1.46 0.98 1.78 -0.35 -1.23
Interest Coverage Ratio
4.73 2.45 2.06 -0.70 -2.16
Debt to Market Cap
0.18 0.49 0.52 0.81 0.25
Interest Debt Per Share
0.97 2.65 2.82 3.19 3.41
Net Debt to EBITDA
-0.26 0.57 1.82 -9.92 -0.93
Profitability Margins
Gross Profit Margin
72.33%73.40%75.83%74.84%82.50%
EBIT Margin
21.85%15.28%5.28%-6.32%-20.32%
EBITDA Margin
26.59%20.17%9.20%-2.13%-17.12%
Operating Profit Margin
19.35%13.85%10.39%-3.51%-13.51%
Pretax Profit Margin
17.76%9.62%0.22%-11.37%-26.57%
Net Profit Margin
20.35%9.16%0.40%-11.49%-26.65%
Continuous Operations Profit Margin
20.35%9.16%<0.01%-11.50%-26.65%
Net Income Per EBT
114.60%95.22%182.40%101.04%100.33%
EBT Per EBIT
91.78%69.47%2.11%323.67%196.71%
Return on Assets (ROA)
24.86%9.37%0.41%-12.84%-24.57%
Return on Equity (ROE)
53.09%40.40%4.22%1212.50%1000.00%
Return on Capital Employed (ROCE)
39.77%24.89%16.39%-7.61%-23.39%
Return on Invested Capital (ROIC)
34.65%18.29%0.00%-7.24%-20.28%
Return on Tangible Assets
32.59%12.73%0.60%-18.14%-35.28%
Earnings Yield
18.39%10.58%0.48%-23.55%-14.78%
Efficiency Ratios
Receivables Turnover
9.19 4.86 5.65 7.78 8.81
Payables Turnover
12.15 9.10 8.56 5.70 3.26
Inventory Turnover
7.67 8.85 12.17 8.96 11.41
Fixed Asset Turnover
74.02 27.25 18.23 16.05 11.92
Asset Turnover
1.22 1.02 1.03 1.12 0.92
Working Capital Turnover Ratio
4.61 4.15 5.23 8.13 4.19
Cash Conversion Cycle
57.27 76.22 51.92 23.60 -38.46
Days of Sales Outstanding
39.73 75.11 64.60 46.89 41.42
Days of Inventory Outstanding
47.60 41.23 29.98 40.73 32.00
Days of Payables Outstanding
30.05 40.11 42.66 64.03 111.87
Operating Cycle
87.33 116.34 94.58 87.62 73.42
Cash Flow Ratios
Operating Cash Flow Per Share
0.89 0.57 -0.35 0.51 0.02
Free Cash Flow Per Share
0.89 0.30 -0.51 0.51 -0.49
CapEx Per Share
<0.01 0.27 0.16 0.00 0.51
Free Cash Flow to Operating Cash Flow
1.00 0.53 1.44 1.00 -24.06
Dividend Paid and CapEx Coverage Ratio
378.97 2.14 -2.26 0.00 0.04
Capital Expenditure Coverage Ratio
378.97 2.14 -2.26 0.00 0.04
Operating Cash Flow Coverage Ratio
1.16 0.24 -0.14 0.18 <0.01
Operating Cash Flow to Sales Ratio
0.19 0.11 -0.07 0.08 <0.01
Free Cash Flow Yield
16.56%7.04%-12.07%16.76%-4.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
5.44 9.45 207.21 -4.25 -6.77
Price-to-Sales (P/S) Ratio
1.12 0.87 0.83 0.49 1.80
Price-to-Book (P/B) Ratio
2.52 3.82 8.75 -51.48 -67.68
Price-to-Free Cash Flow (P/FCF) Ratio
6.04 14.20 -8.29 5.97 -21.10
Price-to-Operating Cash Flow Ratio
5.94 7.56 -11.96 5.97 507.56
Price-to-Earnings Growth (PEG) Ratio
0.20 <0.01 -2.01 0.08 0.24
Price-to-Fair Value
2.52 3.82 8.75 -51.48 -67.68
Enterprise Value Multiple
3.96 4.86 10.83 -32.81 -11.46
Enterprise Value
250.66M 231.00M 227.05M 177.08M 441.70M
EV to EBITDA
3.96 4.86 10.83 -32.81 -11.46
EV to Sales
1.05 0.98 1.00 0.70 1.96
EV to Free Cash Flow
5.67 16.08 -9.96 8.55 -22.95
EV to Operating Cash Flow
5.65 8.55 -14.37 8.55 552.13
Tangible Book Value Per Share
1.18 -0.16 -1.10 -1.69 -2.02
Shareholders’ Equity Per Share
2.11 1.13 0.48 -0.06 -0.15
Tax and Other Ratios
Effective Tax Rate
-0.16 0.05 1.00 -0.01 >-0.01
Revenue Per Share
4.79 5.00 5.10 6.23 5.69
Net Income Per Share
0.97 0.46 0.02 -0.72 -1.52
Tax Burden
1.15 0.95 1.82 1.01 1.00
Interest Burden
0.81 0.63 0.04 1.80 1.31
Research & Development to Revenue
0.24 0.21 0.23 0.28 0.43
SG&A to Revenue
0.22 0.38 0.39 0.46 0.53
Stock-Based Compensation to Revenue
0.03 0.04 0.05 0.13 0.16
Income Quality
0.92 1.25 -7.90K -0.71 -0.01
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis